Baader Helvea upgraded Newron Pharma to Buy from Add with a CHF 13.60 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Baader Helvea upgraded Newron Pharma to Buy from Add with a CHF 13.60 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>